FTC Stretches its Review Arm into Biopharma Licensing
By Mari Serebrov
Tuesday, August 14, 2012
The long arm of the Federal Trade Commission (FTC) is about to stretch even further into biopharma business.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.